Medaffcon
Bettina Mannerström is a highly experienced scientific advisor with extensive expertise in project management for Medical and Real-World Evidence (RWE) initiatives across multiple disease areas. Currently at Medaffcon, Bettina manages projects in Finnish, English, and Swedish, including stakeholder mapping, compliance reviews, and scientific writing. Previously, at Eli Lilly and Company, Bettina provided medical support for diabetes and obesity research, maintaining collaborations with key opinion leaders. Bettina's academic background includes senior researcher roles at the University of Helsinki and University of Tampere, where contributions focused on clinical applications and supervision of students. Bettina holds a Ph.D. in Tissue Engineering from the University of Tampere and a Title of Docent in Cell and Molecular Biology from the University of Helsinki.
This person is not in any teams
Medaffcon
Medaffcon Oy is a Finnish consulting and service company. We provide research and expert services for the needs of the pharmaceutical and health technology industries and healthcare fields in Finland, Nordic countries and elsewhere in Europe. We have been operating since 2009. We are known for our strong expertise, swiftness and flexibility. The effectiveness of our operations is based on strong contents and process know-how. Our experts have a broad international experience in managerial and expert positions in the pharmaceutical sector. Our expertise extensively represents the fields of Health Economics, Medical and Natural Sciences as well as Data Sciences. We are thoroughly acquainted with the processes in the field and we can take over different projects even on a short-term schedule. Our solutions are always tailored to the customer’s needs. Our services include: - Real World Evidence based studies - Pricing and reimbursement processes - Treatment path and stakeholder mapping - Health economic modelling - Expert resourcing - Risk-sharing agreements - Training At Medaffcon, we are devoted to providing means for data-driven decision-making in healthcare and working towards economically sustainable, effective and more individualized treatment care. We believe that Finland is at the forefront of developing tomorrow’s healthcare and mapping the treatment paths of the future. Interested to hear more? Visit our website or send us an email to info@medaffcon.fi